| INTRODUCTION
The evolution of inflammatory bowel disease (IBD) epidemiology has encompassed the emergence of the disease in the developed world from the early to mid-20th century and the emergence of IBD in the developing world in the past 30 years. However, the rising incidence of IBD in the developed world has not followed a continuously linear trajectory. Recent data from Canada suggest that there has been a plateau in the rise in incidence among adults but with an ongoing rising incidence among young children. [1] [2] [3] While the new IBD markets in the world have included developing countries such as China and India, they have also included industrialised countries such as Japan and South Korea. 4 Hence, a consideration that the emergence of IBD in the developing world has been secondary to industrialisation of societies in terms of diets, food additives, medications, vaccinations and urbanisation may be too simplified and does not account for the changing epidemiology of long modernised Asian countries. Nonetheless, those are phenomena that have relatively rapidly changed worldwide in the past 100 years and warrant important consideration. However, it is not simply enough to contrast the developing world of China, for example, with the West, but also
China and its neighbour Japan; and also when persons from developing countries immigrate to developed countries.
Twenty-five years ago it was first reported that first generation Britons born to immigrants from South Asia had comparable rates of ulcerative colitis as expected from the general British population; enforcing the notion that environment had a larger role to play in disease evolution than genetics. 5 Similar findings have been reported from a paediatric clinic in Vancouver, Canada where South Asian children growing up in Canada presented as commonly to the paediatric IBD clinic as Caucasian Canadians. 6 It is also known that identical twins have incomplete penetrance of disease expression so concordance rate for the second twin getting Crohn's disease is less than 50%; and it is even less for ulcerative colitis. 7 Hence, it is necessary to look to the environment for causes of IBD. Since IBD presents more or less with similar phenotypes worldwide 8 one needs to consider environmental triggers that are common worldwide.
In attempting to posit aetiologic hypotheses based on the evolving epidemiology of these diseases the following factors must be accounted for:
1. The highest incidence rates of these diseases continue to be in the developed world however, incidence rates are not uniformly rising suggesting that aetiologic factor(s) are still present and whatever is triggering IBD in the developed world currently is unlikely to be novel compared to several years ago when the incidence was rising.
2.
In the developed world children have the highest rate of rise of incidence suggesting that the aetiologic factor(s) is being increasingly experienced by children.
3. In the developing world the incidence rate is rising and considering that in general the phenotypes of IBD are comparable regardless of the continent on which the disease is diagnosed, it is very possible that the aetiologic factor(s) are similar across the world. The rate of caesarean section birth was nearly identical among the groups (IBD = 11.6%, controls = 11.7%, siblings = 11.3%). In this same study, we were able to discern breastfeeding initiation rates by the time of discharge from the hospital at birth. The rates were not significantly different (IBD = 83.5%, controls = 79.3%, siblings = 79.5%).
Using the same database the next study we undertook was to determine if maternal antibiotic use would impact on the child's ultimate development of IBD. We found there were no differences in maternal antibiotic use 9 months antepartum, within 30 days antepartum, or in hospital peripartum in persons with IBD compared to healthy controls or sibling controls. 19 Synthesizing these data, it appears that events that can change the neonatal gut microbiome do not pose a risk for the ultimate development of IBD. Hence, it may be that alterations in the neonate's microbiome can be overcome by events of the months ahead as the infant's microbiome is developing; breastfeeding duration, dietary introduction, experiencing gastrointestinal infections and drug administrations later in that first year may be more important.
Again using the University of Manitoba IBD Epidemiology Database we assessed whether children with IBD were significantly more likely to have used antibiotics in the first year of life than matched unaffected controls. 20 We found that the relative risk of children with IBD having used antibiotics in their first year of life was nearly threefold that of controls. Vaccinations are another childhood intervention that if not altering the gut microbiota could alter the systemic immune response.
There is limited research exploring the association between vaccine use and development of IBD on a population basis. In one study using the University of Manitoba IBD Epidemiology Database persons with IBD were compared to controls for seropositivity to measles, mumps and rubella as an indirect measure of having received vaccine (MMR). 24 Of course many seropositive individuals may have incurred natural infections for any of these three viruses.
Not surprisingly, the vast majority of the entire study cohort was seropositive since MMR is widely administered to Manitoba children.
This made finding significant differences in seropositivity status more problematic. However, it was shown that persons with IBD were not significantly more likely to be seropositive to measles (adjusted odds ratio, AOR: 1.5; 95% CI: 0.5-4.4). This study did not support that either vaccination or natural infection to measles (or mumps or rubella) were associated with IBD development.
Breastfeeding is a healthy behaviour conferring enhanced childhood protection and providing infants with a significantly distinct intestinal microbiota than formula-fed infants. Several studies have assessed the binary outcome of breastfeeding or no breastfeeding
and there have been conflicting results. A meta-analysis has suggested that overall it confers a benefit without specifying age of disease onset 25 and a second meta-analysis specified protection for children developing IBD (OR, 0.69; 95% CI, 0.51-0.94). 26 What is missing from these analyses are duration of breastfeeding as well as whether breastfeeding is the sole nutrient source or rather, is supplemented by formula or later in the first year table foods. Even childhood diets limited to milk lead to different faecal microbiota depending on the type of milk, including when breast milk is mixed with formula milk. 27 The most recent meta-analysis also reported that ever being breastfed was associated with a lower risk of Prospective studies exploring breastfeeding exclusivity and duration in relation to other feeding types and their association with IBD are much needed.
| USING E PIDEMIOLOGY TO STUDY THE RISK FOR IBD IN ADULTS
It is more difficult to pursue aetiologic studies in adults in relation to IBD development because they have had more varied life experiences than children. Survey studies of adults are limited by recall bias. In one population based study from Manitoba, persons with IBD were more likely to have had tap water (than well or lake water)
as their primary water source as a child whereas a population based study from France suggested that persons with IBD were less likely to have tap water as their primary water source. 29, 30 In comparing these disparate results it would be necessary to determine the dif- through 1995, the daily intake of dairy products and meat increased, paralleling the increase in the incidence of UC. The trends of the increase in the incidence of UC and the increase in the daily intake of meat were very similar. Hence, it is plausible that adults can trigger a persistent change in their microbiota that may be conducive to IBD by adding or subtracting certain foodstuffs to their usual diet. 40, 41 In a prospective study of more than 400 persons with ulcerative colitis undergoing treatment with aminosalicylates, dietary intake was concurrently assessed. The investigators determined that a diet particularly including myristic acid (commonly found in palm oil, coconut oil and dairy fats) was associated with an increased risk of flare (OR = 3.01; 95% CI 1.17-7.74). 42 Another area that warrants study is that of food additives such as emulsifiers and how it may impact on both the microbiome and the intestinal immune response. 43 that short courses of ciprofloxacin in healthy humans can have longlasting effects on some gut microbial taxa. 44, 45 Using the University of Manitoba IBD Epidemiology Database we have shown that adults with IBD were 1.5 times more likely to have been prescribed antibiotics up to 5 years prior to disease diagnosis than matched controls. 46 In In a meta-analysis of 33 eligible studies comparing outcomes in
Crohn's disease among smokers with nonsmokers, smokers had an increased odds of flare of disease activity (OR = 1.56; 95% CI, 1.21-2.01), flare after surgery (OR = 1.97; 95% CI, 1.36-2.85), need for first surgery (OR = 1.68; 95% CI, 1.33-2.12) and need for second surgery (OR = 2.17; 95% CI, 1.63-2.89). 50 The odds of these outcomes among ex-smokers diminished upon smoking cessation, with odds ratios comparable to those among nonsmokers and, in the case of flare or second surgery, significantly lower than smokers. That smoking exacerbates Crohn's disease does not necessarily translate into being causative of Crohn's disease.
The mechanisms as to how smoking impacts on the evolution of either form of IBD is unknown. Smoke-exposed and air-exposed mice were compared after a smoke exposure of 24 weeks. Bacterial activity and community structure were significantly altered in the colon due to smoke exposure. Notably, an increase of Lachnospiraceae sp. activity in the colon was observed. 51 Smoke exposure also altered mRNA expression of intestinal mucins and cytokines. In a study of persons with Crohn's disease and healthy controls both those with Crohn's disease and healthy controls who were smokers compared to non smokers had significantly higher levels of Bacteroides-Prevotella in their gut microbiota. 52 Over a period of 9 weeks with repeated stool sampling of five persons continuing to smoke and five persons who quit smoking marked shifts in the microbial composition after smoking cessation were observed. 53 There was an increase of Firmicutes (Clostridium coccoides, Eubacterium rectale, and Clostridium leptum subgroup) and Actinobacteria and a lower proportion of Bacteroidetes (Prevotella spp. and Bacteroides spp.) and Proteobacteria on the phylum level. In addition, One study compared 21 smokers to 21 non smokers all of whom had Crohn's disease. 55 Compared with nonsmokers, gut microbial gene richness (P < .01), genus diversity (P = .01), and species diversity (P = .01) were decreased in smokers. This was accompanied by a reduced relative abundance of the genera Collinsella (P = .02),
Enterorhabdus (P = .02), and Gordonibacter (P = .02) in smokers.
There is ample evidence that smoking modifies the outcomes of Crohn's disease however whether it is causative remains in question.
It is noteworthy that countries with the highest rates of Crohn's disease have among the lowest rates of adult male smoking while countries with low rates of Crohn's disease have among the highest rates of adult male smokers. 56 Table 1 , Figures 1, and 2 for a review of the main factors found to be associated with protection against or risk for developing IBD and Table 2 for suggestions for prospective epidemiological studies that may shed light on IBD aetiology. Any factors that are found to be associated with a form of IBD or protective of a form of IBD will have to be followed up with mechanistic studies to help assure researchers that the associations are not spurious. 
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